ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,051.85
0.67%
Dow Jones
38,144.26
0.64%
US Dollar vs MXN
16.94185
-0.01%
Brent Oil
83.73
0.23%
Bitcoin
59,035.26
1.37%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Denali Therapeutics Inc (DNLI)

  7. Denali Therapeutics Inc (DNLI) Noticias

DNLI Denali Therapeutics Inc

16.59
0.43 (2.66%)
Última actualización: 12:19:27
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Denali Therapeutics Inc DNLI NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.43 2.66% 16.59 12:19:27
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
16.41 15.92 16.61 16.16
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/5/202407:00GLOBEDenali Therapeutics Announces Completion of Enrollment for..
01/3/202415:51EDGAR2Form D - Notice of Exempt Offering of Securities
27/2/202407:07EDGAR2Form 8-K - Current report
27/2/202407:05GLOBEDenali Therapeutics Reports Fourth Quarter and Full Year..
27/2/202407:03EDGAR2Form 8-K - Current report
27/2/202407:00GLOBEDenali Therapeutics Announces $500 million Private Placement..
16/2/202407:02EDGAR2Form 8-K - Current report
15/2/202420:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202420:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202420:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202415:59EDGAR2Form 144 - Report of proposed sale of securities
14/2/202415:43EDGAR2Form 144 - Report of proposed sale of securities
13/2/202419:19EDGAR2Form 144 - Report of proposed sale of securities
13/2/202419:18EDGAR2Form 144 - Report of proposed sale of securities
13/2/202419:17EDGAR2Form 144 - Report of proposed sale of securities
12/2/202415:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202407:00GLOBEDenali Therapeutics Announces New Data and Expansion of Its..
01/2/202407:00GLOBEDenali Therapeutics Announces Presentations on Its..
12/1/202419:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202416:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202415:09EDGAR2Form 144 - Report of proposed sale of securities
09/1/202418:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202418:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202418:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202418:20EDGAR2Form 144 - Report of proposed sale of securities
08/1/202407:06EDGAR2Form 8-K - Current report
08/1/202407:00GLOBEDenali Therapeutics Announces Key Anticipated 2024..
05/1/202419:25EDGAR2Form 144 - Report of proposed sale of securities
05/1/202416:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202416:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202416:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202318:01PRNUSFlagship Pioneering Marks Official Opening of UK Hub with..
21/11/202305:00PRNUSFlagship Pioneering Unveils Quotient Therapeutics to Create..
07/11/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202315:04EDGAR2Form 8-K - Current report
07/11/202315:01GLOBEDenali Therapeutics Reports Third Quarter 2023 Financial..
01/11/202309:30PRNUSFlagship Pioneering Launches Pioneering Intelligence
11/9/202305:30PRNUSFlagship Pioneering Announces Appointment of Amanda Kay as..
30/8/202307:30GLOBEDenali Therapeutics Announces New Interim Data from Phase..
29/8/202308:00PRNUSInvaio achieves first registration for citrus greening..
25/8/202316:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202315:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202315:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202315:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202315:07EDGAR2Form 144 - Report of proposed sale of securities
23/8/202315:06EDGAR2Form 144 - Report of proposed sale of securities
21/8/202315:06EDGAR2Form 8-K - Current report
21/8/202313:47EDGAR2Form 144 - Report of proposed sale of securities
21/8/202313:45EDGAR2Form 144 - Report of proposed sale of securities

Su Consulta Reciente

NASDAQ
DNLI
Denali Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados